Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Yuexin Zhou et al.
NATURE (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells
Ignazio Maggio et al.
SCIENTIFIC REPORTS (2014)
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang et al.
CELL (2013)
One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
Hui Yang et al.
CELL (2013)
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting
Bin Shen et al.
CELL RESEARCH (2013)
Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos
Nannan Chang et al.
CELL RESEARCH (2013)
Highly Efficient Genome Modifications Mediated by CRISPR/Cas9 in Drosophila
Zhongsheng Yu et al.
GENETICS (2013)
Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease-Targeted Disruption of the HIV Co-receptor CCR5
Dawn A. Maier et al.
HUMAN GENE THERAPY (2013)
Trimeric Glycosylphosphatidylinositol-Anchored HCDR3 of Broadly Neutralizing Antibody PG16 Is a Potent HIV-1 Entry Inhibitor
Lihong Liu et al.
JOURNAL OF VIROLOGY (2013)
Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
Lijing Li et al.
MOLECULAR THERAPY (2013)
A CRISPR/Cas system mediates bacterial innate immune evasion and virulence
Timothy R. Sampson et al.
NATURE (2013)
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Seung Woo Cho et al.
NATURE BIOTECHNOLOGY (2013)
Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination
Daniel J. Dickinson et al.
NATURE METHODS (2013)
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
Ari E. Friedland et al.
NATURE METHODS (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system
Li-En Jao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
The Genomic and Transcriptomic Landscape of a HeLa Cell Line
Jonathan J. M. Landry et al.
G3-GENES GENOMES GENETICS (2013)
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages
Christina Ochsenbauer et al.
JOURNAL OF VIROLOGY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
HIV Transmission
George M. Shaw et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China
Hong Shang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Potent and Broad Anti-HIV-1 Activity Exhibited by a Glycosyl-Phosphatidylinositol-Anchored Peptide Derived from the CDR H3 of Broadly Neutralizing Antibody PG16
Lihong Liu et al.
JOURNAL OF VIROLOGY (2011)
Evolution and classification of the CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2011)
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
Claudio Mussolino et al.
NUCLEIC ACIDS RESEARCH (2011)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
GPI-anchored single chain Fv - an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike
Michael Wen et al.
RETROVIROLOGY (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly
Hye Joo Kim et al.
GENOME RESEARCH (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase
Cheguo Tsai et al.
VACCINE (2009)
CCR5 as target for HIV-1 gene therapy
Reza Nazari et al.
CURRENT GENE THERAPY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Denise L. Kothe et al.
VIROLOGY (2007)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery
C. H. Swan et al.
GENE THERAPY (2006)
Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor
M Chelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
A Follenzi et al.
NATURE GENETICS (2000)